Recently, the same authors reported that C5a released by GA‐MSCs increases ZEB1 levels in GBM cells through the activation of C5aR1 and p38 MAPK signaling, promoting the invasiveness of GBM without modifying growth rate in vitro. This evidence concerns the gene ZEB1 and glioblastoma.